Cargando…
What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3)
Reactive antigenic epitopes on presumed autoantigens of biologic interest have been examined by many researchers. The central third complementarity-determining region (CDR3) residues of a human monoclonal anti-proteinase 3 (PR3) antibody contained many negatively charged aspartic acid residues, perh...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC130014/ https://www.ncbi.nlm.nih.gov/pubmed/11094437 http://dx.doi.org/10.1186/ar97 |
_version_ | 1782120373027864576 |
---|---|
author | Peen, Elisabeth Ralph C, Williams |
author_facet | Peen, Elisabeth Ralph C, Williams |
author_sort | Peen, Elisabeth |
collection | PubMed |
description | Reactive antigenic epitopes on presumed autoantigens of biologic interest have been examined by many researchers. The central third complementarity-determining region (CDR3) residues of a human monoclonal anti-proteinase 3 (PR3) antibody contained many negatively charged aspartic acid residues, perhaps contributing to its reactivity with positively charged PR3 regions. Examination of four other human monoclonal anti-PR3 antibodies shows a number of negatively charged residues within their CDR3 regions. Mapping of segments of linear PR3-epitopes reacting with anti-neutrophil cytoplasmic antibodies (ANCA) demonstrated a preliminary estimate of structures contributing to antigenic determinants. T-cell epitopes on PR3 are reported in studies of chronic myeloid leukemia. These T-cell epitopes appear to be human leukocyte antigen (HLA) A2.1 restricted. |
format | Text |
id | pubmed-130014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1300142002-10-28 What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3) Peen, Elisabeth Ralph C, Williams Arthritis Res Review Reactive antigenic epitopes on presumed autoantigens of biologic interest have been examined by many researchers. The central third complementarity-determining region (CDR3) residues of a human monoclonal anti-proteinase 3 (PR3) antibody contained many negatively charged aspartic acid residues, perhaps contributing to its reactivity with positively charged PR3 regions. Examination of four other human monoclonal anti-PR3 antibodies shows a number of negatively charged residues within their CDR3 regions. Mapping of segments of linear PR3-epitopes reacting with anti-neutrophil cytoplasmic antibodies (ANCA) demonstrated a preliminary estimate of structures contributing to antigenic determinants. T-cell epitopes on PR3 are reported in studies of chronic myeloid leukemia. These T-cell epitopes appear to be human leukocyte antigen (HLA) A2.1 restricted. BioMed Central 2000 2000-06-12 /pmc/articles/PMC130014/ /pubmed/11094437 http://dx.doi.org/10.1186/ar97 Text en Copyright © 2000 Current Science Ltd |
spellingShingle | Review Peen, Elisabeth Ralph C, Williams What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3) |
title | What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3) |
title_full | What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3) |
title_fullStr | What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3) |
title_full_unstemmed | What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3) |
title_short | What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3) |
title_sort | what you should know about pr3-anca: structural aspects of antibodies to proteinase 3 (pr3) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC130014/ https://www.ncbi.nlm.nih.gov/pubmed/11094437 http://dx.doi.org/10.1186/ar97 |
work_keys_str_mv | AT peenelisabeth whatyoushouldknowaboutpr3ancastructuralaspectsofantibodiestoproteinase3pr3 AT ralphcwilliams whatyoushouldknowaboutpr3ancastructuralaspectsofantibodiestoproteinase3pr3 |